Rational targeted therapeutics for double-hit lymphoma

Nancy G Azizian; Yuanhui Liu; Lan V Pham; Yulin Li

doi:10.2217/ijh-2019-0009

Rational targeted therapeutics for double-hit lymphoma

Nancy G Azizian, Yuanhui Liu, Lan V Pham, Yulin Li

Research output: Contribution to journal › Article › peer-review

Abstract

"Double-hit lymphomas with MYC and BCL2 translocations can be effectively treated by combined targeting of the driver oncogenes".

Original language	English (US)
Pages (from-to)	IJH19
Journal	International Journal of Hematologic Oncology
Volume	8
Issue number	3
DOIs	https://doi.org/10.2217/ijh-2019-0009
State	Published - Aug 21 2019

Divisions

Medical Oncology

Access to Document

10.2217/ijh-2019-0009

Cite this

@article{f9017497250c4cae9930d156216e479e,

title = "Rational targeted therapeutics for double-hit lymphoma",

abstract = "{"}Double-hit lymphomas with MYC and BCL2 translocations can be effectively treated by combined targeting of the driver oncogenes{"}.",

author = "Azizian, \{Nancy G\} and Yuanhui Liu and Pham, \{Lan V\} and Yulin Li",

note = "{\textcopyright} 2019 Yulin Li.",

year = "2019",

month = aug,

day = "21",

doi = "10.2217/ijh-2019-0009",

language = "English (US)",

volume = "8",

pages = "IJH19",

journal = "International Journal of Hematologic Oncology",

issn = "2045-1393",

publisher = "Future Medicine Ltd.",

number = "3",

}

TY - JOUR

T1 - Rational targeted therapeutics for double-hit lymphoma

AU - Azizian, Nancy G

AU - Liu, Yuanhui

AU - Pham, Lan V

AU - Li, Yulin

PY - 2019/8/21

Y1 - 2019/8/21

N2 - "Double-hit lymphomas with MYC and BCL2 translocations can be effectively treated by combined targeting of the driver oncogenes".

AB - "Double-hit lymphomas with MYC and BCL2 translocations can be effectively treated by combined targeting of the driver oncogenes".

U2 - 10.2217/ijh-2019-0009

DO - 10.2217/ijh-2019-0009

M3 - Article

C2 - 31850145

SN - 2045-1393

VL - 8

SP - IJH19

JO - International Journal of Hematologic Oncology

JF - International Journal of Hematologic Oncology

IS - 3

ER -

Rational targeted therapeutics for double-hit lymphoma

Abstract

Divisions

Access to Document

Fingerprint

Cite this